NCT07099742View on ClinicalTrials.gov

Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

Not yet recruitingOBSERVATIONAL

Enrollment

364

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions

Obesity

Interventions

DRUG

Tirzepatide

Exposure

BEHAVIORAL

Life Style Modification

Referent group - Lifestyle interventions, exercise, and diet control

Trial Locations (3)

Unknown

Trauma Centre, Cumilla., Comilla

Dhaka Medical College Hospital, Dhaka, Dhaka

Rajshahi Medical College Hospital, Rajshahi, Rajshahi

All Listed Sponsors

lead

Dr. Md. Alimur Reza

INDUSTRY

NCT07099742 - Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter